Home | About Us | Our Products | Our Facilites | Quality Assurance | Feed Back | Contact Us
 

5th May 2009
Dolphin has added seven more formulations to its growing Sri Lanka Portfolio

28th April 2009
The Board of Directors of the Company in its 154th meeting held on Tuesday, 28 April, 2009 has recommended 50% cash and 25% stock dividend (bonus share)

Decotrim Suspension
Back
 Description

Decotrim Suspension is a preparation of co-trimoxazole, a chemotherapeutic agent effective against a wide range of Gram-positive and Gram-negative organisms.

 Indications

Decotrim Suspension is indicated in:
Respiratory tract infections : Acute and chronic bronchitis, bronchiectasis, lobar and broncho-pneumonia, otitis media and sinusitis .
Genito-urinary tract infections : Urethritis, cystitis, pyelonephritis, prostatitis, and gonorrhoea in penicillin allergic patients.
Gastrointestinal infections : Typhoid and paratyphoid fever, chronic carriage if Salmonella typhi and paratyphi, cholera and shigellosis.
Skin infections : Pyoderma, abscesses and wound infections .
Other bacterial infections : Acute and chronic osteomyelitis, acute brucellosis, septicaemia and other infections caused by sensitive pathogens

 Dosage & administration

Decotrim Suspension Children :
6 weeks to 6 months : 2.5 ml (½ teaspoonful) twice daily.
6 months to 6 years : 5 ml (1 teaspoonful) twice daily .
6 -12 years : 10 ml (2 teaspoonful ) twice daily.
In acute infections, Decotrim Suspension should be given for at least 5 days or until the patient has been symptom free for 2 days.

 Contraindications

Decotrim Suspension should not be given to patient with a history of hypersensitivity to sulphonamide, trimethoprim or co-trimoxazole. It is contraindicated in patients showing marked liver parenchymal damage and in severe renal insufficiency. It should not be given in pregnancy, in patients with serious haematological disorders and in infants under 6 weeks.

 WARNINGS

In prolonged treatment, complete blood count is to be performed at monthly intervals in renal impairment, a modified dosage schedule is indicated and adequate fluid intake is required. It is to be taken with caution during breast feeding. Treatment should be discontinued if skin rash appears.

 Side effects

Nausea, vomiting, skin rashes, glossitis can occur, Decotrim-DSmay cause thrombocytopenia, purpura, leucopenia & very rarely agranulocytosis.

 PHARMACEUTICAL PRECAUTION

Store in a cool dry place, away from light. Keep out of the reach of children.

 Packaging:

Decotrim-Suspension : Bottle containing 60 ml suspension. Each 5 ml contains co-trimoxazole 240 mg.


www.dolphinpharmaltd.com-Copyright © 2009 - All rights reserved. Designed by: www.linuxoptic.com